Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-NAPA Antibody (R1Z04)

Catalog #:   RHF07001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IF, IHC, WB
Accession: P54920
Overview

Catalog No.

RHF07001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IF: 1:50-1:200, IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

SNAPA, N-ethylmaleimide-sensitive factor attachment protein alpha, SNAP-alpha, NAPA, Alpha-soluble NSF attachment protein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P54920

Applications

IF, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Z04

Data Image
  • Western blot
    Western blot analysis of Alpha SNAP expression in Molt4 cell lysate.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
  • Western blot
    All lanes use the Antibody at 1:2K dilution for 1 hour at room temperature.
References

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial., PMID:40120616

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial., PMID:39974075

Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy., PMID:39919903

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors., PMID:39637943

The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts., PMID:39533217

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial., PMID:37577112

The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19., PMID:36843665

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance., PMID:36787696

A Randomized, Placebo-Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings., PMID:36099211

Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set., PMID:35944232

Transient recombinant expression of highly immunogenic CagA, VacA and NapA in Nicotiana benthamiana., PMID:35028298

Characterization and Management of Treatment-emergent Hepatic Toxicity in Patients with Advanced Renal Cell Carcinoma Receiving First-line Pembrolizumab plus Axitinib. Results from the KEYNOTE-426 Trial., PMID:34244116

Helicobacter pylori Immunoproteomic Profiles in Gastric Cancer., PMID:33108201

Definition of Naturally Processed Peptides Reveals Convergent Presentation of Autoantigenic Topoisomerase I Epitopes in Scleroderma., PMID:32162841

Designing a novel ELISA method based on CagA, NapA recombinant antigens to increase sensitivity and specificity of Helicobacter pylori whole cell antigen detection., PMID:30425813

Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules., PMID:29787590

Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity., PMID:29691472

Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study., PMID:28888185

Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013., PMID:28737284

Helicobacter pylori Seropositivity and Childhood Neurodevelopment, the Rhea Birth Cohort in Crete, Greece., PMID:28640520

Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma., PMID:26447895

Helicobacter pylori blood biomarker for gastric cancer risk in East Asia., PMID:27170766

Serum Helicobacter pylori FliD antibody and the risk of gastric cancer., PMID:26968951

An Unusual Outbreak of Chlamydiosis in Commercial Turkeys Involving the Nasal Glands., PMID:26473684

Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas., PMID:26383162

Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer., PMID:26251258

Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015., PMID:26136239

Helicobacter pylori antibody patterns in Germany: a cross-sectional population study., PMID:24782915

Serum Helicobacter pylori NapA antibody as a potential biomarker for gastric cancer., PMID:24553293

TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels., PMID:24418856

Experimental infection of dogs with various Bartonella species or subspecies isolated from their natural reservoir., PMID:24315039

A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology., PMID:24259284

Helicobacter pylori protein-specific antibodies and risk of colorectal cancer., PMID:24045925

Presenting a foreign antigen on live attenuated Edwardsiella tarda using twin-arginine translocation signal peptide as a multivalent vaccine., PMID:23994481

Newly-diagnosed pediatric epilepsy is associated with elevated autoantibodies to glutamic acid decarboxylase but not cardiolipin., PMID:23538270

Immunization with the immunodominant Helicobacter suis urease subunit B induces partial protection against H. suis infection in a mouse model., PMID:23101660

Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel., PMID:22927132

CD99/MIC2 Constitutes a Differentiation Antigen of a Human Osteoblast Cell Line., PMID:29147265

Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi., PMID:20851780

Helicobacter pylori multiplex serology., PMID:19889070

Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis., PMID:18975343

Sodium phenylacetate inhibits the Ras/MAPK signaling pathway to induce reduction of the c-Raf-1 protein in human and canine breast cancer cells., PMID:18953652

Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies., PMID:18720546

[Clone, expression and immunoreaction of napA gene of Helicobacter pylori]., PMID:17488595

Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli., PMID:15637768

Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients., PMID:15637759

Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals., PMID:15591500

NapF is a cytoplasmic iron-sulfur protein required for Fe-S cluster assembly in the periplasmic nitrate reductase., PMID:15371424

Mutagenesis study on the role of a lysine residue highly conserved in formate dehydrogenases and periplasmic nitrate reductases., PMID:14511645

Decrease of breast cancer cell invasiveness by sodium phenylacetate (NaPa) is associated with an increased expression of adhesive molecules., PMID:11259095

Datasheet

Document Download

Anti-NAPA Antibody (R1Z04).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-NAPA Antibody (R1Z04) [RHF07001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only